跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ERFA-AMIKACIN - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
ERFA-AMIKACIN
Authorized
STANDARD
ERFA-AMIKACIN
searchlight pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
b6a0ff547c6ef551
Company
searchlight pharma inc
Type
Standard
Approval Details
Approval Id
b6a0ff547c6ef551
Drug Approval Canada Name
ERFA-AMIKACIN
Product Name
ERFA-AMIKACIN
Status
Cancelled Post Market
Status Date
2024-11-22
Original Market Date
2019-11-29
Din
02489147
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Intravenous , Intramuscular
Schedule
Prescription
Ahfs
08:12.02
Atc Original
J01GB06 AMIKACIN
Atc Name
j 01 gb 06
Aig Number
0111922001
Company Name
searchlight pharma inc
Company Address
1600 Rue Notre Dame Ouest, Suite 312, Montreal, Quebec, Canada, H3J 1M1
Active Ingredients
AMIKACIN (AMIKACIN SULFATE)
250 MG / ML
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
b6a0ff547c6ef551
Type
Standard
Back to Health Canada Approvals